Annual Report for 2004 Aflac
Financial Highlights
Our Mission and Philosophy
Cover Story
Composition of Aflac's Market in Japan and the United States
Message from Management
Q & A with the CEO
Aflac Japan
Aflac U.S.
OFFERED AS PDF
Selected Financial Data
Management's Discussion and Analysis
Consolidated Financial Statements
Notes to the Consolidated Financial Statements
Investor Information
Glossary
Board of Directors and Management
Aflac Duck
Aflac U.S.
PART 5 OF 6
Previous Next
Photo
Dr. Thomas A. Olson focuses on pediatric hematology/oncology at the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta, pictured here sharing a chuckle with some of the center's young patients. Joining him from left to right are Caitlin Donahue, 6; Conrad Cornell, 9; Robin Haralson, 8; and D.J. Whatley, 7. Over the years, the Aflac family has pledged approximately $25 million to the center. As a national leader among childhood cancer, hematology, and blood and marrow transplant programs, the Aflac Cancer Center's state-of-the-art facility treats more than 300 newly diagnosed cancer patients and follows nearly 1,500 patients with sickle cell disease, hemophilia and other blood disorders.
AFLAC U.S. · PART 5 OF 6
Previous Next
CONTACT INFORMATION SITE MAP DOWNLOAD THIS REPORT AFLAC.COM